Resets for biotech, antibiotics approval not enough, continued consolidation, and a normal deal

Find out more athttps://LifeScienceTodayPodcast.com

Story ReferencesZymeworks
Phathom
Catalyst
CenExel
Intercept + Advanz
About the ShowLife Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.